Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.31 USD | -1.77% | +0.53% | -11.27% |
05-14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
05-13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |